The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects

NCT04591301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: HEC113995 PA•H2O tablets
DRUG: Placebo tablets

Sponsor

Sunshine Lake Pharma Co., Ltd.